Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes

Схожие документы

• High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
  по: Gadd, Adam J.R., et al.
  Опубликовано: (2018)
• A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent Manner
  по: Auderset, Floriane, et al.
  Опубликовано: (2020)
• Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
  по: Milicic, Anita, et al.
  Опубликовано: (2012)
• In Vitro Evaluation of TLR4 Agonist Activity: Formulation Effects
  по: Misquith, Ayesha, et al.
  Опубликовано: (2013)
• Intravesical Toll-like receptor 7 agonist R-837: Optimization of its formulation in an orthotopic mouse model of bladder cancer
  по: Hayashi, Tomoko, et al.
  Опубликовано: (2010)